This is a different post in that I am going to be focusing on proprietary data and analysis. Below is summary of the findings and then I will talk more generally about the data. This should be of value and if there are particular ways in which you would like to see the data or […]
March 11th Biotech Update
The FDA has been a little active recently and not only from changes but also from controversies. I think that some of the changes certainly could be seen as tailwinds but the increased variability of decisions and actions are perhaps more important. Even if announced changes are positive, when the industry has to make capital […]
February 11th Biotech Update
The still dominated by the metabolic franchise, with GLP-1s representing one of the largest value creation cycles in sector history. One has to think that the fate of this market plays a large part of generalist interest going forward. Shares of NOVO and LLY have been highly sensitive to competitive dynamics, supply constraints, and incremental […]
January 23rd Biotech Update
The sector continues to plod along. I think there is some interesting news with the oral GLP launch and while it certainly has import for the companies involved, I think the sector does best when there is a big launch that creates buzz outside the sector. It is the generalists that really push bull markets […]
October 14th Biotech Update
Over the past few days, biotech and pharmaceutical stocks have seen mixed but generally positive moves sparked by deal news and strong individual performers. This environment reinforces the more positive sentiment around the sector but with a preference now being placed on pipelines with strong differentiation, regulatory path clarity, or acquisition potential. It seems the […]
October 10th Biotech Update
There is a lot still to summarize and talk about and I will be slowly chipping away at what I see are key developments for the broader market as well as those companies I have followed in the past. This has a little bit of both to end the week. BTIG hosted a webcast with […]
June 24th Biotech Update
Looks like events are settling down in the Middle East and while there are still risks, it looks like everyone is taking the offramps (for now). This should decrease the price of oil and increase the risk tolerance of the market. Of course, the sector did not do great when it appeared to settle down […]
April 5th Biotech Update
So, we are at the area where we have bounced off of what might be a major bottom and have basically closed a gap to the upside. The market is overbought and that is likely the case for the sector as well. All of this being said, it seem like a natural place for a […]
April 29th Biotech Update
I see a lot more green on my screen than the XBI seems to indicate but I see this as generally a productive day for the sector. There is a lot of news to digest that just came out today and so some I may leave until tomorrow. Overall, I still think we have likely […]
February 21st Biotech Update
Did we have a clearing event with the confirmation of RFK JR or is that copium? The initial indication is that there has been a little relief rally and if we can keep as close to the old status quo as possible (not too many massive changes) and rates can come down then the sector […]
February 11th Biotech Update
Still not looking great for the sector. While there is not a ton of positive news to move the sector forward, rates are starting to tick higher. Perhaps this is only a momentary move, and we will reverse lower on rates but if rates start a more consistent move higher, then there is no shot […]
January 24th Biotech Update
Well, the sector is doing a little better but we are still not out of the woods. I would feel better once we break out of the recent high. We do not want to be in a situation where we set a lower high. We are close but need to get above $95 before we […]
January 6th Biotech Update
We are now making our way out of holiday trading and into what I would say is the first real trading day of the new year. I still think the sector trading will be focused on the upcoming JPM meeting next week and so whatever happens this week can change dramatically next. The key is […]
November 4th Biotech Update
I do not expect any major changes until at least Wednesday. That assumes that we have some sort of election clarity (hopefully). Even then I am not sure what is best for the sector. I would usually assume that a Republican win would be better but some are naturally getting nervous about RFK role in […]
October 30th Biotech Update
Not much to say about the sector as we continue in the range and are a little higher today as we move towards the upper end of the range. Of course, it is always nicer to be near the higher end than the lower end but as always the expectation should always be that we […]
July 8th Biotech Update
It is going to be an interesting week. We have been pretty slow on the news front and last week was a holiday week with the expected dry up in volume. I get that it is still summer, and trading is going to remain slow but coming off of a holiday we get some interesting […]
May 31st Biotech Update
Nothing really to add on the sector or market in general. It is all about inflation and rates and will be so for the foreseeable future. The sector has been struggling a little and I think probably a little more than I would have originally expected. I understand that rates are heading up a little […]
May 17th Biotech Update
It has been a pretty good week for the sector with a nice steady move higher. It has not be an absolute straight line nor has it been dramatic one but a slow build higher is not too bad. In some ways, this is better than an accelerating move as this provides more volume at […]
March 25th Biotech Update
While the sector certainly seems to be holding up around support, this does not feel like a good place for the sector. The market and tech sectors are at highs and we are struggling to bounce off of what should be pretty strong levels of support. The small caps are not doing as well as […]
February 12th Biotech Update
I feel like the sector is in a better place to start this week than the start of last week. I have been thinking that we are closer to the end of the consolidation than the beginning and the trading last week reinforced that view. If we can build on that move early this week, […]
